CircRNA-associated ceRNA network reveals ErbB and Hippo signaling pathways in hypopharyngeal cancer

Chun Feng, Yuxiao Li, Yan Lin, Xianbao Cao, Dong‐Dong Li, Honglei Zhang, Xiaoguang HeInternational Journal of Molecular Medicine 2018 · DOI

Abstract

Accumulating evidence has suggested that circular RNAs (circRNAs), a novel class of non‑coding RNAs, have crucial roles in tumor progression. However, the significance of circRNAs in hypopharyngeal cancer (HCa) remains to be investigated. The present study has identified aberrantly expressed circRNAs by performing circRNA sequencing analyses of three pairs of tumor and adjacent normal samples from patients with HCa. The results demonstrated that 173 circRNAs were differentially expressed (DE), including 71 upregulated and 102 downregulated circRNAs. Pathway analyses of the genes producing DE circRNAs revealed that many of them were involved in cancer‑related pathways. To further illustrate the roles of circRNAs in HCa progression, a competing endogenous RNA (ceRNAs) network was constructed, consisting of circRNAs, miRNA, and miRNA targeted genes. The results demonstrated that multiple cancer‑related pathways were affected by performing enrichment analyses of the targeted genes. Of note, a ceRNA subnetwork was isolated, consisting of two circRNAs (hsa_circ_0008287 and hsa_circ_0005027) and one miRNA (hsa‑miR‑548c‑3p), which significantly affect both ErbB and Hippo signaling pathways. In conclusion, the present study identified a set of circRNAs that are potentially implicated in the tumorigenesis of HCa and may serve as potential biomarkers for the diagnosis of HCa.

Introduction

Hypopharyngeal cancer (HCa) is a particularly aggressive malignancy of the upper digestive tract. Because it rarely shows specific symptoms in its early stages, it is often diagnosed late; roughly 60–80% of patients already have lymph node metastases by the time they are seen by a doctor. Consequently, survival rates are low, and there is a desperate need for stable, early-stage biomarkers.

Circular RNAs (circRNAs) are a novel class of non-coding RNAs that form closed loops, making them highly resistant to degradation. While circRNAs can act as "sponges" that neutralize microRNAs (miRNAs)—thereby preventing those miRNAs from silencing specific genes—their exact role in HCa was largely unknown prior to this research. This study maps the landscape of circRNAs in HCa to identify potential diagnostic biomarkers and therapeutic targets.

Methodology

The researchers employed a multi-stage discovery and validation pipeline:

  1. CircRNA Sequencing: High-throughput sequencing was performed on three pairs of HCa tumors and adjacent normal tissues.
  2. Bioinformatics Pipeline: The CIRI pipeline was used to identify circular junctions, and the RPM (reads per million) method was used to normalize expression levels.
  3. Network Construction: To understand the "sponge" effect, a competing endogenous RNA (ceRNA) network was built, predicting miRNA binding to identified circRNAs and downstream gene targets.
  4. Validation: RT-qPCR was used to verify the expression of 19 candidate circRNAs in a larger pool of samples.
  5. In-silico Cross-Validation: TCGA esophageal carcinoma data was used as a proxy to validate the clinical relevance and survival impact of identified miRNA targets.

Results

Identification of Differentially Expressed circRNAs

The study identified 173 circRNAs that were significantly differentially expressed in HCa tumors compared to normal tissues (FDR < 0.05 and fold change ≥2 or ≤0.5). This included 71 upregulated and 102 downregulated circRNAs. Principal Component Analysis (PCA) and heatmap clustering confirmed that the expression profiles of tumor samples were distinct from those of normal tissues.

PCA and heatmap analysis of differentially expressed circRNAs in HCa tumor vs. normal tissues.

Validation and Pathway Analysis

RT-qPCR confirmed that 12 out of 19 tested circRNAs followed the expression patterns predicted by the sequencing data. Specifically, several circRNAs were significantly downregulated in tumor tissues, suggesting a loss of regulatory "brakes" in cancer cells.

RT-qPCR validation of 12 differentially expressed circRNAs in HCa.

Pathway enrichment analysis of the genes producing these DE circRNAs revealed involvement in cancer-related pathways. A specific ceRNA subnetwork was identified involving two circRNAs (hsa_circ_0008287 and hsa_circ_0005027) and one miRNA (hsa-miR-548c-3p). This axis significantly affects both the ErbB and Hippo signaling pathways, which are critical for cell proliferation and organ size regulation.

Discussion

The findings suggest that the downregulation of specific circRNAs in HCa leads to the release of oncogenic miRNAs, which then activate growth-promoting signaling pathways. Using TCGA proxy data, the researchers showed that high expression of hsa-miR-548c-3p is associated with lower survival rates. While limited by a small discovery cohort and a lack of functional "wet lab" validation, this study provides a high-resolution map of the circRNA-associated ceRNA network in HCa, highlighting potential biomarkers for early diagnosis.

Summary updated

Abstract

Accumulating evidence has suggested that circular RNAs (circRNAs), a novel class of non‑coding RNAs, have crucial roles in tumor progression. However, the significance of circRNAs in hypopharyngeal cancer (HCa) remains to be investigated. The present study has identified aberrantly expressed circRNAs by performing circRNA sequencing analyses of three pairs of tumor and adjacent normal samples from patients with HCa. The results demonstrated that 173 circRNAs were differentially expressed (DE), including 71 upregulated and 102 downregulated circRNAs (FDR<0.05 and fold changes of ≥2 or ≤0.5 by Mann‑Whitney U test followed by Benjamini‑Hochberg correction for multiple testing). Pathway analyses of the genes producing DE circRNAs revealed that many of them were involved in cancer‑related pathways. To further illustrate the roles of circRNAs in HCa progression, a competing endogenous RNA (ceRNAs) network was constructed, consisting of circRNAs, miRNA, and miRNA targeted genes. The results demonstrated that multiple cancer‑related pathways were affected by performing enrichment analyses of the targeted genes. Of note, a ceRNA subnetwork was isolated, consisting of two circRNAs (hsa_circ_0008287 and hsa_circ_0005027) and one miRNA (hsa‑miR‑548c‑3p), which significantly affect both ErbB and Hippo signaling pathways. In conclusion, the present study identified a set of circRNAs that are potentially implicated in the tumorigenesis of HCa and may serve as potential biomarkers for the diagnosis of HCa.
BibTeX
@article{feng2018circrna,
  author = {Chun Feng and Yuxiao Li and Yan Lin and Xianbao Cao and Dong‐Dong Li and Honglei Zhang and Xiaoguang He},
  title = {{CircRNA-associated ceRNA network reveals ErbB and Hippo signaling pathways in hypopharyngeal cancer}},
  journal = {International Journal of Molecular Medicine},
  year = {2018},
  doi = {10.3892/ijmm.2018.3942},
}
Figure